Comparative pharmacokinetics of factor VIII and recombinant factor IX: for which coagulation factors should half-life change with age?
about
The History of Clotting Factor Concentrates PharmacokineticsPharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.A bodyweight-dependent allometric exponent model for scaling clearance of clotting factor VIII and IX from infants to adults.Population pharmacokinetics of recombinant coagulation factor VIII-SingleChain in patients with severe hemophilia A.Recombinant factor IX (BAX326) in previously treated paediatric patients with haemophilia B: a prospective clinical trial.Pharmacokinetic characterization of recombinant factor XIII (FXIII)-A2 across age groups in patients with FXIII A-subunit congenital deficiency.
P2860
Comparative pharmacokinetics of factor VIII and recombinant factor IX: for which coagulation factors should half-life change with age?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Comparative pharmacokinetics o ...... uld half-life change with age?
@en
Comparative pharmacokinetics o ...... uld half-life change with age?
@nl
type
label
Comparative pharmacokinetics o ...... uld half-life change with age?
@en
Comparative pharmacokinetics o ...... uld half-life change with age?
@nl
prefLabel
Comparative pharmacokinetics o ...... uld half-life change with age?
@en
Comparative pharmacokinetics o ...... uld half-life change with age?
@nl
P2860
P356
P1433
P1476
Comparative pharmacokinetics o ...... uld half-life change with age?
@en
P2093
S Björkman
P2860
P304
P356
10.1111/HAE.12253
P577
2013-11-01T00:00:00Z